Crossject S.A Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €1.67 High: €1.71
on August 22, 2025

52 Week Range

Low: €0.72 High: €2.75
on April 11, 2025
on October 22, 2024

All-Time High: €13.09 on February 24, 2014

Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights

Key Statistics

Market Cap i €85.4M
EPS i -0.28
P/E Ratio (TTM) i N/A
Forward P/E i 7.65
P/B Ratio i N/A
PEG Ratio i 7.65
Div. Yield i N/A
ROE i 478.68%
Beta i 0.836
Debt to Equity i -7.88

Financial Highlights

Profitability

Gross Margin i N/A
Operating Margin i -246.47%
Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -26.91%
Return on Equity (TTM) i 478.68%
EBITDA i €-12.0M
Net Income (TTM) i €-12.8M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €0.09
Quarterly Revenue Growth (YoY) i 227.30%
Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Crossject S.A ALCJ 85.42M Small-cap1.82%3.07%0.00%-5.08%-25.00%-28.51%-56.70%-55.79%
EssilorLuxottica EL 123.50B Large-cap3.38%11.70%4.45%-6.50%16.14%26.57%79.07%139.75%
Sartorius Stedim DIM 17.27B Large-cap-0.40%-7.43%-11.07%-13.75%-4.75%-0.65%-53.41%-40.52%
Visiomed Group SA ALVMG 53.17M Small-cap5.00%16.67%16.67%0.00%23.53%23.53%-48.78%-80.19%
Bonyf N.V MLBON 7.77M Small-cap0.00%0.00%-18.35%-33.51%-28.33%-19.38%7.50%3.20%
Spineway S.A ALSPW 4.61M Small-cap0.00%8.33%8.33%0.00%44.44%8.33%8.33%8.33%

Ownership & Short Interest

Insider Ownership i 19.81%
Institutional Ownership i 0.18%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 157K
Average 90-Day Volume i 187K

Crossject S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Crossject S.A would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Crossject S.A reached a high of €2.75 (on October 22, 2024) and a low of €0.72 (on April 11, 2025).
Curious about Crossject S.A's size and valuation? Its market capitalization stands at 85.42M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is 7.65.
As for dividends, Crossject S.A isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Crossject S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
EssilorLuxottica
EL
123.50BHealthcareMedical Instruments & Supplies26.57%79.07%
Sartorius Stedim
DIM
17.27BHealthcareMedical Instruments & Supplies-0.65%-53.41%
Visiomed Group SA
ALVMG
53.17MHealthcareMedical Instruments & Supplies23.53%-48.78%
Bonyf N.V
MLBON
7.77MHealthcareMedical Instruments & Supplies-19.38%7.50%
Spineway S.A
ALSPW
4.61MHealthcareMedical Instruments & Supplies8.33%8.33%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Crossject S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 478.68%, the Debt to Equity ratio from the most recent quarter is -7.88, and its Gross Profit Margin stands at N/A.
Looking at Crossject S.A's growth, its revenue over the trailing twelve months (TTM) was €4M. Compared to the same quarter last year (YoY), quarterly revenue grew by 227.30%, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Crossject S.A stock? Company insiders (like executives and directors) hold about 19.81% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.18%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.